Immediate Impact
57 standout
Citing Papers
Novel strategies to manage CAR-T cell toxicity
2025 Standout
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Works of Elizabeth Budde being referenced
The Bcl‐2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML
2019
Ex Vivo AKT Inhibition Promotes the Generation of Potent CD19CAR T Cells for Adoptive Immunotherapy
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Elizabeth Budde | 154 | 48 | 101 | 85 | 26 | 266 | |
| Sandra P. Susanibar-Adaniya | 161 | 45 | 114 | 49 | 27 | 301 | |
| Sanbin Wang | 128 | 49 | 64 | 97 | 28 | 231 | |
| Kathleen Ruehle | 206 | 59 | 77 | 119 | 24 | 280 | |
| Daniel Egan | 116 | 47 | 73 | 119 | 21 | 198 | |
| George Mo | 158 | 79 | 86 | 47 | 17 | 318 | |
| Evgenii Shumilov | 98 | 18 | 80 | 173 | 32 | 288 | |
| Tontanai Numbenjapon | 142 | 108 | 57 | 98 | 19 | 300 | |
| Liya Ma | 90 | 27 | 99 | 111 | 36 | 284 | |
| Anna Truppel-Hartmann | 218 | 63 | 140 | 126 | 22 | 279 | |
| Edwin Kingsley | 151 | 50 | 101 | 96 | 24 | 294 |
All Works
Loading papers...